NIDA Initiative Selected Psychoactive Drug Study

The research team classified various drugs by analyzing unique brain-wide neuronal activation patterns.

Updated on Oct. 6, 2026 in Substance Abuse

Isometric editorial illustration of a complex crystalline neural structure in teal and slate blue, representing a scientific classification framework. — The National Institute on Drug Abuse selected a study by Farid Aboharb et al. for its October 2026 paper of the month, highlighting a new method for classifying drugs based on brain-wide neural activation. AI Illustration. Upload story photo >

Live Poll

Do you believe brain-wide imaging research is improving our understanding of how psychoactive drugs function?

The NIDA Technology Resource Initiative Committee has selected a paper by Aboharb et al. as its paper of the month for October 2026. The study successfully categorized psychoactive drugs based on distinct brain-wide cellular c-Fos expression patterns.

Why it matters

This research provides a new framework for organizing psychoactive compounds into functional categories based on how they specifically stimulate neural activity. By moving beyond traditional classifications, the study offers a clearer understanding of how different substances interact with the brain.

Researchers utilized high-dimensional c-Fos mapping combined with multivariate statistical classification to group compounds. The study successfully determined that psychoactive drugs create distinct, classifiable brain-wide neuronal activation patterns.

The players

NIDA Technology Resource Initiative Committee

This is a body within the National Institute on Drug Abuse Intramural Research Program that highlights significant advancements in neuroscience research.

Farid Aboharb

He is the lead author of the study detailing the classification of psychoactive drugs based on brain-wide cellular imaging.

The details

The study, authored by Farid Aboharb and colleagues, analyzed how various drugs evoke c-Fos expression throughout the brain. By observing these activation signatures, the team was able to group disparate compounds into clusters based on shared neural effects.

The paper was selected as the NIDA Technology Resource Initiative Committee paper of the month in October 2026.

The Big Picture

This study follows the established research priorities of the NIDA Intramural Research Program by advancing methodology for neurobiological drug characterization.

This research provides a more precise map of how psychoactive drugs function, which could eventually refine how medical professionals understand drug-induced brain changes. The findings offer a scientific foundation for better categorizing substances based on their biological impact rather than just behavioral effects.

The takeaway

By quantifying brain activity at a granular level, scientists are creating a more rigorous way to study drug pharmacology. This methodology offers a promising path for researchers to better predict how various compounds affect human neural pathways.